| Literature DB >> 32726328 |
Rabia Naz1, Thomas H Roberts2, Asghari Bano3, Asia Nosheen1, Humaira Yasmin1, Muhammad Nadeem Hassan1, Rumana Keyani1, Sami Ullah4, Wajiha Khan5, Zahid Anwar6.
Abstract
Jacaranda mimosifolia trees are grown in frost-free regions globally. The aim of this study was to evaluate the methanol crude extract and various fractions of increasing polarity of J. mimosifolia leaves for bioactive metabolites, as well as antimicrobial, antioxidant and anticancer activities. The anti-inflammatory potential of the various fractions of J. mimosifolia leaf extract was studied via the lipoxygenase (LOX) inhibitory assay. Methanol crude extract (ME), derived fractions extracted with chloroform (CF) and ethyl acetate (EAF), and residual aqueous extract (AE) of dried J. mimosifolia leaves were assayed for polyphenolic compounds, their antioxidant, antimicrobial and lipoxygenase (LOX) inhibitory activities, and anticancer properties. Polyphenolic compounds were determined via HPLC while phytochemicals (total phenolics, flavonoids, tannins and ortho-diphenol contents), antioxidant activities (DPPH, hydrogen peroxideperoxide, hydroxyl and superoxide radical anions) and LOX were measured via spectrophotometry. Methanol extracts and various fractions were evaluated for antibacterial activities against Bacillus subtilis, Klebsiella pneumonia, Pseudomonas aeruginosa and Staphylococcus aureus. Antifungal potential of the fractions was tested against three species: Aspergillus flavus, Aspergillus fumigatus and Fusarium oxysporum. The highest values for total phenolic content (TPC), total flavonoid content (TFC), flavonols, tannins and ortho-diphenols were in the ME, followed by CF > EAF > AE. ME also had the highest antioxidant activity with EC50 values 48±1.3, 45±2.4, 42±1.3 and 46±1.3 μg/mL based on the DPPH, hydrogen peroxide, hydroxyl radical and superoxide radical assays, respectively. TPC and TFC showed a significant, strong and positive correlation with the values for each of these antioxidant activities. ME exhibited anti-inflammatory potential based on its LOX inhibitory activity (IC50 = 1.3 μg/mL). ME also had the maximum antibacterial and antifungal potential, followed by EAF > CF > AE. Furthermore, ME showed the strongest cytotoxic effect (EC50 = 10.7 and 17.3 μg/mL) against human hormone-dependent prostate carcinoma (LnCaP) and human lung carcinoma (LU-1) cell lines, respectively. Bioactive compounds present in leaf methanol extracts of J. mimosifolia were identified using gas chromatography-mass spectrometry (GC-MS). Fifteen compounds were identified including phenolic and alcoholic compounds, as well as fatty acids. Our results suggest that J. mimosifolia leaves are a good source of natural products with antioxidant, anti-inflammatory and anti-cancer properties for potential therapeutic, nutraceutical and functional food applications.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32726328 PMCID: PMC7390342 DOI: 10.1371/journal.pone.0236319
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Presence/absence of major phytochemical groups in J. mimosifolia leaf extracts and fractions.
| Class of metabolites | ME | AE | CF | EAF |
|---|---|---|---|---|
| Alkaloids | + | + | + | + |
| Phenolics | + | + | + | + |
| Flavonoids | + | + | + | + |
| Tannins | + | + | + | + |
| Saponins | + | + | + | + |
| Terpenoids | + | + | + | − |
| Phlobetannins | + | − | − | + |
| Coumarins | + | − | + | − |
ME, methanol extract; AE, aqueous extract (from ME residue); CF, chloroform fraction from ME crude extract; EAF, ethyl acetate fraction from ME.
Total phenolic, flavonoid, flavonol, tannin and ortho-diphenol contents in J. mimosifolia leaf extracts and fractions.
| Extract/ fraction | TPC (mg GAE /g DW) | TFC (mg RE/g DW) | TFLC (mg RE/g DW) | TT (mg/g DW) | ORTH (mg GAE/g DW) | Extract yield (%) |
|---|---|---|---|---|---|---|
| 125.8a±3.3 | 85.7a±0.32 | 19.1a±0.14 | 2.6a±0.16 | 119.4a±2.7 | 16.3 | |
| 54.6c±2.8 | 53.1c±0.27 | 9.28d±0.16 | 0.77c±0.21 | 48.3d±1.8 | 12.2 | |
| 93.4b±3.2 | 76.9b±0.35 | 14.6b±0.11 | 1.98b±0.18 | 84.6b±2.3 | 9.6 | |
| 92.7b±2.5 | 75.3b±0.29 | 12.4c±0.09 | 1.96b±0.16 | 82.9c±2.2 | 8.5 |
TPC, total phenolic content; TFC, total flavonoid content; TFLC, total flavonol content; TT, total tannin; ORTH, Ortho-diphenols
Data represent mean ± standard deviation (SD) of three biological replicates. All mean values in the same column with different letters are significantly different from each other at P< 0.05.
Major polyphenolic compounds of J. mimosifolia leaf extracts and fractions as quantified by HPLC analysis.
| Compound identified | ME | AE | CE | EAE | ||||
|---|---|---|---|---|---|---|---|---|
| RT (min) | Contents (mg/g extract) | RT (min) | Content (mg/g extract) | RT (min) | Content (mg/g extract) | RT (min) | Contents (mg/g extract) | |
| apigenin | 4.5 | 3.31e±0.93 | - | nd | - | - | - | nd |
| caffeic acid | 21.4 | 7.34cd±1.5 | 27.7 | 6.31d±1.6 | 22.3 | 7.16cd±1.3 | 21.9 | 6.68d±1.1 |
| catechin | 26.7 | 9.68bc±1.7 | 27.3 | 6.75d±1.1 | 26.9 | 9.62bc±1.5 | 26.7 | 7.93cd±1.3 |
| gallic acid | 11.6 | 0.97g±0.05 | 13.7 | 0.39i±0.06 | 11.8 | 0.88gh±0.07 | 12.4 | 0.64h±0.09 |
| kaempferol | 3.3 | 2.24f±0.92 | - | nd | 4.3 | 2.18f±1.05 | - | |
| isoquercetin | 5.8 | 14.91a±2.3 | - | nd | 6.4 | 12.76ab±1.7 | - | |
| rutin | 8.5 | 11.55b±1.9 | - | nd | 8.9 | 9.5bc±1.5 | 9.2 | 8.81c±1.4 |
| 7.3 | 2.97ef±0.85 | - | nd | 7.9 | 2.67ef±0.67 | 8.5 | 2.19f±0.75 | |
Data represent mean ± standard deviation (SD) of three biological replicates. All mean values in the same column with different letters are significantly different from each other at P< 0.05.
Fig 1Antioxidant activities of J. mimosifolia leaf extracts and fractions at various concentrations.
Data represent mean ± standard deviation (SD) of three biological replicates. (A) DPPH radical scavenging activity, (B) Hydrogen peroxide radical scavenging activity, (C) Hydroxyl radical scavenging activity, (D) Superoxide radical scavenging activity. GA, gallic acid; AA, ascorbic acid.
Radical scavenging activities of J. mimosifolia leaf extracts and fractions.
| Extract/standard compound | EC50 values (μg/mL) for radical scavenging | |||
|---|---|---|---|---|
| DPPH | H2O2 | •OH | O2- | |
| ME | 48c±1.3 | 45bc±2.4 | 42bc±1.3 | 46c±1.3 |
| AE | 120a±3.4 | 93a±3.5 | 85a±3.6 | 93a±3.5 |
| CF | 52bc±2.5 | 48b±1.3 | 43b±2.4 | 48c±2.4 |
| EAF | 55b±3.1 | 47b±2.7 | 45b±2.7 | 55b±2.7 |
| GA | 35de±1.1 | 38cd±2.5 | 28d±1.1 | 35d±1.3 |
| AA | 40d±2.6 | 42c±2.8 | 39c±1.6 | 42cd±1.4 |
Data represent mean ± standard deviation (SD) of three biological replicates. GA, gallic acid; AA, ascorbic acid
Fig 2Reducing power of J. mimosifolia leaf extracts and fractions at different concentrations.
Data represent mean ± standard deviation (SD) of three biological replicates.
Correlation matrix between the quantified phytochemicals and antioxidant activities.
| TPC | TFC | TFLC | TT | ORTH | DPPH | H2O2 | •OH | O2- | |
|---|---|---|---|---|---|---|---|---|---|
| TFC | 0.97 | ||||||||
| 0.97 | 0.92 | ||||||||
| 0.99 | 0.997 | 0.93 | |||||||
| 0.998 | 0.96 | 0.976 | 0.976 | ||||||
| 0.942 | 0.859 | 0.99 | 0.883 | 0.959 | |||||
| 0.979 | 0.939 | 0.998 | 0.951 | 0.985 | 0.981 | ||||
| 0.964 | 0.887 | 0.989 | 0.911 | 0.978 | 0.996 | 0.985 | |||
| 0.995 | 0.954 | 0.986 | 0.969 | 0.999 | 0.970 | 0.993 | 0.985 | ||
| 0.992 | 0.967 | 0.987 | 0.976 | 0.993 | 0.961 | 0.995 | 0.973 | 0.996 |
Significance of correlations: *p < 0.05: Significant correlation;
** p < 0.01: Very significant correlation;
***p < 0.001: Extremely significant correlation
Fig 3LOX inhibitory activities of J. mimosifolia methanol extract and soluble fractions expressed as IC50 (μg/mL).
Data represent mean ± standard deviation (SD) of three biological replicates.
Fig 4Zone of inhibition of J. mimosifolia methanol extract and different fractions against pathogenic bacterial strains.
Data represent mean ± standard deviation (SD) of three biological replicates.
MIC values for J. mimosifolia leaf extracts and fractions.
| Test Bacteria | MIC (mg/mL) | ||||
|---|---|---|---|---|---|
| ME | AE | CE | EAE | PC | |
| 1.5d±0.02 | 10.0a±0.3 | 2.5c±0.02 | 5.0b±0.1 | 0.05g±0.01 | |
| 5.0b±0.01 | Nd | 5.0b±0.07 | 10.0a±0.05 | 0.20f±0.03 | |
| 2.5c±0.02 | 10.0a±0.1 | 1.5d±0.03 | 5.0b±0.07 | 0.05g±0.05 | |
| 5.0b±0.1 | N.d. | N.d. | 10.0a±0.2 | 0.25e±0.03 | |
Data represent mean ± standard deviation (SD) of three biological replicates. N.d., not detected
Antifungal potential of J. mimosifolia extracts and fractions.
| Test Fungus | Percentage inhibition (%) | ||||
|---|---|---|---|---|---|
| ME | AE | CE | EAE | Terbinafine | |
| 94.2a±7.5 | 76.6ef±4.9 | 82.5de±7.7 | 89.6c±5.9 | 90.9bc±5.5 | |
| 90.6bc±6.9 | 70.9f±7.5 | 79.7e±6.5 | 87.9cd±5.5 | 89.3c±6.4 | |
| 95.3a±6.5 | 79.3e±4.5 | 85.2d±6.5 | 92.9b±6.5 | 95.7a±6.9 | |
Data represent mean ± standard deviation (SD) of three biological replicates.
Fig 5Analysis of cytotoxic activity of J. mimosifolia extracts and fractions against growth of hormone-dependent prostrate carcinoma (LnCaP-1) cells.
Data represent mean ± standard deviation (SD) of three biological replicates.
Fig 6Analysis of cytotoxic activity of J. mimosifolia extracts and fractions against growth of human lung carcinoma (LU-1) cells.
Data represent mean ± standard deviation (SD) of three biological replicates.
Phytochemical compounds identified in the methanol leaf extracts of Jacaranda mimosifolia.
| Peak# | RT | Area% | Name of compound | Molecular formula | MW | Nature of compound | Pharmacological activities |
|---|---|---|---|---|---|---|---|
| 1 | 8.331 | 1.91 | 2-Nonadecanone 2, 4 dinitrophenyl hydrazine | C25H42N4O4 | 462 | Nitrogen compound | |
| 2 | 10.101 | 0.36 | Ethyl iso-allocholate | C26H44O5 | 436 | Steroid | |
| 3 | 10.898 | 0.30 | 4-(3-hydroxy-1-propenyl)-2-methoxy-phenol, | C10H12O3 | 180 | Phenolic compound | |
| 4 | 11.487 | 1.07 | Hexadecanoic acid | C16H32O2 | 256 | Fatty acid | Anti-inflammatory [ |
| 5 | 12.869 | 2.09 | 1-β- | C8H12N4O5 | 269 | ||
| 6 | 14.207 | 0.13 | 2,4-bis(1,1-dimethylethyl)-phenol | C14H22O | 206 | Phenol | |
| 7 | 14.954 | 0.31 | Z,Z-4,16-Octadecadien-1-ol acetate | C20H36O2 | 308 | Acetate compound | No reported activity |
| 8 | 15.747 | 0.21 | 3-Pyridinol | C5H5NO | 95 | No reported activity | |
| 9 | 17.325 | 0.37 | Hexadeca-9-en-1-ol | C16H32O | 240 | Phenolic & Alcoholic compounds | |
| 10 | 17.738 | 0.77 | 1-methyl-2-(3-methylpentyl)-cyclopropane | C10H20 | 140 | No reported activity | |
| 11 | 18.252 | 1.21 | Hexadecanoic acid, methyl ester | C17H34O2 | 270.4 | Esters | Flavor Methyl palmitate has anti-inflammatory and anti-fibrotic effect. It prevents lung inflammation and fibrosis in rats |
| 12 | 21.025 | 0.24 | 9,12-octadecadienoic acid(Z,Z) | C18H32O2 | 280 | Fatty acid, Linolenic acid, methyl ester | Anti-inflammatory, Hypocholesterolemic, Cancer preventive, Hepatoprotective, Nematicide, Insectifuge, Antihistaminic, Antieczemic, Antiacne, 5-Alpha Reductase inhibitor, Antiandrogenic, Antiarthritic, Anticoronary, Insectifuge [ |
| 13 | 22.996 | 0.04 | Beta-elemene | C15H24 | 204.35 | Monocyclic sesquiterpenoid polyalkene | Anti-inflammatory and antitumor properties |
| 14 | 23.2 | 0.21 | Phytol | C20H40O | 296 | Diterpene alcohol | It produces anxiolytic and sedative effects. Antischistosomal [ |
| 15 | 23.45 | 0.07 | Piperidinone, N-[4-bromo-n-butyl]- | C9H16BrNO | 233 | Alkaloid |
RT = retention time; MW = molecular weight
* The biological activities are based on Dr. Duke’s phytochemical and botanical databases [107].